id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2001-N-0566-0004,FDA,FDA-2001-N-0566,Agency Information Collection Activities; Announcement of OMB Approval; New Animal Drugs for Investigational Use,Notice,Notice of Approval,2002-05-06T04:00:00Z,2002,5,,,2025-02-03T19:04:30Z,02-10795,0,0,090000648050b0d0
FDA-2001-N-0566-0003,FDA,FDA-2001-N-0566,Agency Information Collection Activities; Submission for OMB Review; Comment Request; New Animal Drugs for Investigational Use; Correction,Notice,Correction,2002-03-14T05:00:00Z,2002,3,,,2025-02-03T18:58:42Z,02-5922,0,0,090000648050b0ce
FDA-2001-N-0566-0002,FDA,FDA-2001-N-0566,Agency Information Collection Activities; Submission for OMB Review; Comment Request; New Animal Drugs for Investigational Use,Notice,30 Day Proposed Information Collection,2002-01-14T05:00:00Z,2002,1,2002-01-14T05:00:00Z,2002-02-14T04:59:59Z,2025-02-03T18:56:13Z,02-855,0,0,090000648050b0cd
FDA-2001-N-0566-0001,FDA,FDA-2001-N-0566,Agency Information Collection Activities; Proposed Collection; Comment Request; New Animal Drugs for Investigational Use,Notice,60 Day Proposed Information Collection,2001-10-19T04:00:00Z,2001,10,2001-10-16T04:00:00Z,2001-12-18T04:59:59Z,2025-02-03T18:49:59Z,01-25918,0,0,090000648050b0cb